Table 2. Prevalencea of medicines use to treat chronic diseases in Brazil, according to sociodemographic characteristics. PNAUM, Brazil, 2014. (N = 41,433).
| Sociodemographic characteristic | Prevalence of medicines use to treat chronic diseases | |||||
|---|---|---|---|---|---|---|
|
| ||||||
| All | Male | Female | ||||
|
|
|
|
||||
| Prevalence | 95%CI | Prevalence | 95%CI | Prevalence | 95%CI | |
| Age groupb | < 0.001c | < 0.001 | < 0.001 | |||
| 0-4 | 5.7 | 4.8–6.5 | 6.4 | 5.2–7.5 | 5.0 | 3.8–6.1 |
| 5-9 | 5.2 | 3.6–6.8 | 6.0 | 3.4–8.5 | 4.5 | 2.3–6.6 |
| 10-19 | 5.3 | 4.1–6.5 | 4.9 | 3.2–6.5 | 5.7 | 4.0–7.4 |
| 20-29 | 7.5 | 6.1–8.9 | 5.8 | 3.7–7.9 | 9.2 | 7.5–10.8 |
| 30-39 | 14.9 | 13.2–16.5 | 11.2 | 8.5–13.9 | 18.1 | 16.2–19.9 |
| 40-49 | 28.9 | 27.4–30.4 | 20.5 | 18.7–22.4 | 36.4 | 34.3–38.5 |
| 50-59 | 49.9 | 48.0–51.8 | 36.4 | 33.7–39.1 | 60.5 | 58.0–63.0 |
| 60-69 | 66.2 | 64.2–68.1 | 56.7 | 53.7–59.7 | 73.5 | 71.3–75.7 |
| 70-79 | 78.5 | 76.4–80.6 | 71.6 | 67.8–75.5 | 83.2 | 81.1–85.4 |
| ≥ 80 | 79.7 | 75.6–83.8 | 73.4 | 70.7–80.0 | 82.7 | 76.7–88.6 |
| Economic classificationd | 0.011 | 0.033 | 0.038 | |||
| A/B | 26.5 | 24.6–28.4 | 21.0 | 18.6–23.4 | 31.8 | 29.6–34.1 |
| C | 24.2 | 23.0–25.4 | 18.6 | 17.2–20.0 | 29.1 | 27.6–30.6 |
| D | 22.4 | 20.6–24.3 | 16.4 | 14.4–18.4 | 27.4 | 24.9–29.9 |
| E | 23.1 | 19.6–26.6 | 18.2 | 13.7–22.6 | 28.5 | 23.8–33.3 |
| Region | < 0.001 | < 0.001 | < 0.001 | |||
| North | 14.0 | 12.2–15.7 | 11.6 | 9.7–13.5 | 16.1 | 14.0–18.3 |
| Northeast | 20.5 | 18.9–22.1 | 15.4 | 13.6–17.1 | 24.8 | 22.7–27.0 |
| Southeast | 27.5 | 25.7–29.4 | 21.4 | 19.3–23.5 | 33.0 | 30.8–35.3 |
| South | 26.7 | 24.5–28.9 | 19.9 | 17.6–22.3 | 32.8 | 30.4–35.3 |
| Midwest | 23.2 | 21.4–25.1 | 18.0 | 15.8–20.2 | 28.4 | 26.4–30.3 |
| Total | 24.3 | 23.3–25.4 | 18.7 | 17.6–19.9 | 29.4 | 28.1–30.7 |
a Percentages adjusted by sample weights and post-stratification according to age and gender.
b In years.
c Pearson’s Chi-square test.
d The economic classification variable according to the Brazilian Economic Classification Criterion of the Associação Brasileira de Empresas de Pesquisa (http://www.abep.org) had 77 ‘missing’.